VANGUARD BD INDEX FDS - INTERMED TERM (BIV)

CUSIP: 921937819

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / INTERMED TERM
Total 13F shares
54,689,496
Share change
+21,854,226
Total reported value
$4,628,377,574
Put/Call ratio
2547%
Price per share
$84.84
Number of holders
231
Value change
+$1,846,356,101
Number of buys
124
Number of sells
78

Security key

921937819

Report period

Q3 2015

Institutions

231

Top holders

10

Ownership snapshot

Top shareholders of BIV - VANGUARD BD INDEX FDS - INTERMED TERM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q3 2015

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
231
Shares
54,689,496
Rows loaded
231
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q3 2015 vs Q2 2015 Across Filers

Q2 2015 holders
223
Q3 2015 holders
231
Holder diff
8
Investor Q2 2015 Shares Q3 2015 Shares Share Diff Share Chg % Q2 2015 value Q3 2015 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .